《大行報告》花旗:九龍倉置業(01997.HK)去年度核心EBIT強勁 重申屬行業首要買入股份
花旗銀行發報告指九龍倉置業(01997.HK)的股息率非常吸引,因此重申九龍倉置業為行業內的首選買入股。目標價32.7元。
花旗指,九龍倉置業2023年度的基礎淨盈利為60.11億港元,按年跌3%。來自核心業務投資物業和酒店的EBIT升12%,達到94.56億元,符合花旗預期。整體現金財務成本因香港銀行同業拆息(HIBOR)上升而增加90%,至23.33億元。由於公司100%的流動債務結構以及HIBOR或已於2023年下半年見頂,加之全年負債淨額顯著減少,花旗認為九龍倉置業的核心盈利和每股派息已在去年觸底,預計未來收入很大機會上升,利息開支亦會減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.